0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Non-sterile Liquid Market Research Report 2024
Published Date: September 2024
|
Report Code: QYRE-Auto-28W13982
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Non sterile Liquid Market Research Report 2023
BUY CHAPTERS

Global Non-sterile Liquid Market Research Report 2024

Code: QYRE-Auto-28W13982
Report
September 2024
Pages:100
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Non-sterile Liquid Market Size

The global Non-sterile Liquid market was valued at US$ 2600 million in 2023 and is anticipated to reach US$ 3900.9 million by 2030, witnessing a CAGR of 6.0% during the forecast period 2024-2030.

Non-sterile Liquid Market

Non-sterile Liquid Market

Non-sterile liquid can be used to deliver a variety of medications, including prescription drugs, non-prescription drugs, vitamins, dietary supplements, and nutraceuticals.
North American market for Non-sterile Liquid is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Non-sterile Liquid is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Non-sterile Liquid include Nycomed, AbbVie, Aenova, APPCO, Atral Pharmaceutical, Aurigene Pharmaceutical Services, Biological E. Ltd., BioPlus Life Sciences and Bora Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Non-sterile Liquid, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-sterile Liquid.

Report Scope

The Non-sterile Liquid market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Non-sterile Liquid market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-sterile Liquid manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Non-sterile Liquid Market Report

Report Metric Details
Report Name Non-sterile Liquid Market
Accounted market size in 2023 US$ 2600 million
Forecasted market size in 2030 US$ 3900.9 million
CAGR 6.0%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Solution
  • Suspension
  • Gel
  • Syrup
  • Ethanolic Liquid
Segment by Application
  • Human Medication
  • Nutraceuticals
  • Cosmetics
  • Medical Devices
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Nycomed, AbbVie, Aenova, APPCO, Atral Pharmaceutical, Aurigene Pharmaceutical Services, Biological E. Ltd., BioPlus Life Sciences, Bora Pharmaceuticals, Cambrex Corporation, JGL d.d., Mikart, PharmaVision, Pierre Fabre, TriRx Pharmaceutical Services, UI Pharmaceuticals, Wasdell Group
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Non-sterile Liquid manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Non-sterile Liquid in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Non-sterile Liquid Market growing?

Ans: The Non-sterile Liquid Market witnessing a CAGR of 6.0% during the forecast period 2024-2030.

What is the Non-sterile Liquid Market size in 2030?

Ans: The Non-sterile Liquid Market size in 2030 will be US$ 3900.9 million.

Who are the main players in the Non-sterile Liquid Market report?

Ans: The main players in the Non-sterile Liquid Market are Nycomed, AbbVie, Aenova, APPCO, Atral Pharmaceutical, Aurigene Pharmaceutical Services, Biological E. Ltd., BioPlus Life Sciences, Bora Pharmaceuticals, Cambrex Corporation, JGL d.d., Mikart, PharmaVision, Pierre Fabre, TriRx Pharmaceutical Services, UI Pharmaceuticals, Wasdell Group

What are the Application segmentation covered in the Non-sterile Liquid Market report?

Ans: The Applications covered in the Non-sterile Liquid Market report are Human Medication, Nutraceuticals, Cosmetics, Medical Devices

What are the Type segmentation covered in the Non-sterile Liquid Market report?

Ans: The Types covered in the Non-sterile Liquid Market report are Solution, Suspension, Gel, Syrup, Ethanolic Liquid

1 Non-sterile Liquid Market Overview
1.1 Product Overview and Scope of Non-sterile Liquid
1.2 Non-sterile Liquid Segment by Type
1.2.1 Global Non-sterile Liquid Market Value Comparison by Type (2024-2030)
1.2.2 Solution
1.2.3 Suspension
1.2.4 Gel
1.2.5 Syrup
1.2.6 Ethanolic Liquid
1.3 Non-sterile Liquid Segment by Application
1.3.1 Global Non-sterile Liquid Market Value by Application: (2024-2030)
1.3.2 Human Medication
1.3.3 Nutraceuticals
1.3.4 Cosmetics
1.3.5 Medical Devices
1.4 Global Non-sterile Liquid Market Size Estimates and Forecasts
1.4.1 Global Non-sterile Liquid Revenue 2019-2030
1.4.2 Global Non-sterile Liquid Sales 2019-2030
1.4.3 Global Non-sterile Liquid Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Non-sterile Liquid Market Competition by Manufacturers
2.1 Global Non-sterile Liquid Sales Market Share by Manufacturers (2019-2024)
2.2 Global Non-sterile Liquid Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Non-sterile Liquid Average Price by Manufacturers (2019-2024)
2.4 Global Non-sterile Liquid Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Non-sterile Liquid, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Non-sterile Liquid, Product Type & Application
2.7 Non-sterile Liquid Market Competitive Situation and Trends
2.7.1 Non-sterile Liquid Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Non-sterile Liquid Players Market Share by Revenue
2.7.3 Global Non-sterile Liquid Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Non-sterile Liquid Retrospective Market Scenario by Region
3.1 Global Non-sterile Liquid Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Non-sterile Liquid Global Non-sterile Liquid Sales by Region: 2019-2030
3.2.1 Global Non-sterile Liquid Sales by Region: 2019-2024
3.2.2 Global Non-sterile Liquid Sales by Region: 2025-2030
3.3 Global Non-sterile Liquid Global Non-sterile Liquid Revenue by Region: 2019-2030
3.3.1 Global Non-sterile Liquid Revenue by Region: 2019-2024
3.3.2 Global Non-sterile Liquid Revenue by Region: 2025-2030
3.4 North America Non-sterile Liquid Market Facts & Figures by Country
3.4.1 North America Non-sterile Liquid Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Non-sterile Liquid Sales by Country (2019-2030)
3.4.3 North America Non-sterile Liquid Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Non-sterile Liquid Market Facts & Figures by Country
3.5.1 Europe Non-sterile Liquid Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Non-sterile Liquid Sales by Country (2019-2030)
3.5.3 Europe Non-sterile Liquid Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Non-sterile Liquid Market Facts & Figures by Country
3.6.1 Asia Pacific Non-sterile Liquid Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Non-sterile Liquid Sales by Country (2019-2030)
3.6.3 Asia Pacific Non-sterile Liquid Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Non-sterile Liquid Market Facts & Figures by Country
3.7.1 Latin America Non-sterile Liquid Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Non-sterile Liquid Sales by Country (2019-2030)
3.7.3 Latin America Non-sterile Liquid Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Non-sterile Liquid Market Facts & Figures by Country
3.8.1 Middle East and Africa Non-sterile Liquid Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Non-sterile Liquid Sales by Country (2019-2030)
3.8.3 Middle East and Africa Non-sterile Liquid Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Non-sterile Liquid Sales by Type (2019-2030)
4.1.1 Global Non-sterile Liquid Sales by Type (2019-2024)
4.1.2 Global Non-sterile Liquid Sales by Type (2025-2030)
4.1.3 Global Non-sterile Liquid Sales Market Share by Type (2019-2030)
4.2 Global Non-sterile Liquid Revenue by Type (2019-2030)
4.2.1 Global Non-sterile Liquid Revenue by Type (2019-2024)
4.2.2 Global Non-sterile Liquid Revenue by Type (2025-2030)
4.2.3 Global Non-sterile Liquid Revenue Market Share by Type (2019-2030)
4.3 Global Non-sterile Liquid Price by Type (2019-2030)
5 Segment by Application
5.1 Global Non-sterile Liquid Sales by Application (2019-2030)
5.1.1 Global Non-sterile Liquid Sales by Application (2019-2024)
5.1.2 Global Non-sterile Liquid Sales by Application (2025-2030)
5.1.3 Global Non-sterile Liquid Sales Market Share by Application (2019-2030)
5.2 Global Non-sterile Liquid Revenue by Application (2019-2030)
5.2.1 Global Non-sterile Liquid Revenue by Application (2019-2024)
5.2.2 Global Non-sterile Liquid Revenue by Application (2025-2030)
5.2.3 Global Non-sterile Liquid Revenue Market Share by Application (2019-2030)
5.3 Global Non-sterile Liquid Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Nycomed
6.1.1 Nycomed Corporation Information
6.1.2 Nycomed Description and Business Overview
6.1.3 Nycomed Non-sterile Liquid Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Nycomed Non-sterile Liquid Product Portfolio
6.1.5 Nycomed Recent Developments/Updates
6.2 AbbVie
6.2.1 AbbVie Corporation Information
6.2.2 AbbVie Description and Business Overview
6.2.3 AbbVie Non-sterile Liquid Sales, Revenue and Gross Margin (2019-2024)
6.2.4 AbbVie Non-sterile Liquid Product Portfolio
6.2.5 AbbVie Recent Developments/Updates
6.3 Aenova
6.3.1 Aenova Corporation Information
6.3.2 Aenova Description and Business Overview
6.3.3 Aenova Non-sterile Liquid Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Aenova Non-sterile Liquid Product Portfolio
6.3.5 Aenova Recent Developments/Updates
6.4 APPCO
6.4.1 APPCO Corporation Information
6.4.2 APPCO Description and Business Overview
6.4.3 APPCO Non-sterile Liquid Sales, Revenue and Gross Margin (2019-2024)
6.4.4 APPCO Non-sterile Liquid Product Portfolio
6.4.5 APPCO Recent Developments/Updates
6.5 Atral Pharmaceutical
6.5.1 Atral Pharmaceutical Corporation Information
6.5.2 Atral Pharmaceutical Description and Business Overview
6.5.3 Atral Pharmaceutical Non-sterile Liquid Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Atral Pharmaceutical Non-sterile Liquid Product Portfolio
6.5.5 Atral Pharmaceutical Recent Developments/Updates
6.6 Aurigene Pharmaceutical Services
6.6.1 Aurigene Pharmaceutical Services Corporation Information
6.6.2 Aurigene Pharmaceutical Services Description and Business Overview
6.6.3 Aurigene Pharmaceutical Services Non-sterile Liquid Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Aurigene Pharmaceutical Services Non-sterile Liquid Product Portfolio
6.6.5 Aurigene Pharmaceutical Services Recent Developments/Updates
6.7 Biological E. Ltd.
6.6.1 Biological E. Ltd. Corporation Information
6.6.2 Biological E. Ltd. Description and Business Overview
6.6.3 Biological E. Ltd. Non-sterile Liquid Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Biological E. Ltd. Non-sterile Liquid Product Portfolio
6.7.5 Biological E. Ltd. Recent Developments/Updates
6.8 BioPlus Life Sciences
6.8.1 BioPlus Life Sciences Corporation Information
6.8.2 BioPlus Life Sciences Description and Business Overview
6.8.3 BioPlus Life Sciences Non-sterile Liquid Sales, Revenue and Gross Margin (2019-2024)
6.8.4 BioPlus Life Sciences Non-sterile Liquid Product Portfolio
6.8.5 BioPlus Life Sciences Recent Developments/Updates
6.9 Bora Pharmaceuticals
6.9.1 Bora Pharmaceuticals Corporation Information
6.9.2 Bora Pharmaceuticals Description and Business Overview
6.9.3 Bora Pharmaceuticals Non-sterile Liquid Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Bora Pharmaceuticals Non-sterile Liquid Product Portfolio
6.9.5 Bora Pharmaceuticals Recent Developments/Updates
6.10 Cambrex Corporation
6.10.1 Cambrex Corporation Corporation Information
6.10.2 Cambrex Corporation Description and Business Overview
6.10.3 Cambrex Corporation Non-sterile Liquid Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Cambrex Corporation Non-sterile Liquid Product Portfolio
6.10.5 Cambrex Corporation Recent Developments/Updates
6.11 JGL d.d.
6.11.1 JGL d.d. Corporation Information
6.11.2 JGL d.d. Non-sterile Liquid Description and Business Overview
6.11.3 JGL d.d. Non-sterile Liquid Sales, Revenue and Gross Margin (2019-2024)
6.11.4 JGL d.d. Non-sterile Liquid Product Portfolio
6.11.5 JGL d.d. Recent Developments/Updates
6.12 Mikart
6.12.1 Mikart Corporation Information
6.12.2 Mikart Non-sterile Liquid Description and Business Overview
6.12.3 Mikart Non-sterile Liquid Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Mikart Non-sterile Liquid Product Portfolio
6.12.5 Mikart Recent Developments/Updates
6.13 PharmaVision
6.13.1 PharmaVision Corporation Information
6.13.2 PharmaVision Non-sterile Liquid Description and Business Overview
6.13.3 PharmaVision Non-sterile Liquid Sales, Revenue and Gross Margin (2019-2024)
6.13.4 PharmaVision Non-sterile Liquid Product Portfolio
6.13.5 PharmaVision Recent Developments/Updates
6.14 Pierre Fabre
6.14.1 Pierre Fabre Corporation Information
6.14.2 Pierre Fabre Non-sterile Liquid Description and Business Overview
6.14.3 Pierre Fabre Non-sterile Liquid Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Pierre Fabre Non-sterile Liquid Product Portfolio
6.14.5 Pierre Fabre Recent Developments/Updates
6.15 TriRx Pharmaceutical Services
6.15.1 TriRx Pharmaceutical Services Corporation Information
6.15.2 TriRx Pharmaceutical Services Non-sterile Liquid Description and Business Overview
6.15.3 TriRx Pharmaceutical Services Non-sterile Liquid Sales, Revenue and Gross Margin (2019-2024)
6.15.4 TriRx Pharmaceutical Services Non-sterile Liquid Product Portfolio
6.15.5 TriRx Pharmaceutical Services Recent Developments/Updates
6.16 UI Pharmaceuticals
6.16.1 UI Pharmaceuticals Corporation Information
6.16.2 UI Pharmaceuticals Non-sterile Liquid Description and Business Overview
6.16.3 UI Pharmaceuticals Non-sterile Liquid Sales, Revenue and Gross Margin (2019-2024)
6.16.4 UI Pharmaceuticals Non-sterile Liquid Product Portfolio
6.16.5 UI Pharmaceuticals Recent Developments/Updates
6.17 Wasdell Group
6.17.1 Wasdell Group Corporation Information
6.17.2 Wasdell Group Non-sterile Liquid Description and Business Overview
6.17.3 Wasdell Group Non-sterile Liquid Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Wasdell Group Non-sterile Liquid Product Portfolio
6.17.5 Wasdell Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Non-sterile Liquid Industry Chain Analysis
7.2 Non-sterile Liquid Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Non-sterile Liquid Production Mode & Process
7.4 Non-sterile Liquid Sales and Marketing
7.4.1 Non-sterile Liquid Sales Channels
7.4.2 Non-sterile Liquid Distributors
7.5 Non-sterile Liquid Customers
8 Non-sterile Liquid Market Dynamics
8.1 Non-sterile Liquid Industry Trends
8.2 Non-sterile Liquid Market Drivers
8.3 Non-sterile Liquid Market Challenges
8.4 Non-sterile Liquid Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Non-sterile Liquid Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Non-sterile Liquid Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Non-sterile Liquid Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Non-sterile Liquid Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Non-sterile Liquid Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Non-sterile Liquid Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Non-sterile Liquid Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Non-sterile Liquid Average Price (US$/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Non-sterile Liquid, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Non-sterile Liquid, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Non-sterile Liquid, Product Type & Application
    Table 12. Global Key Manufacturers of Non-sterile Liquid, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Non-sterile Liquid by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-sterile Liquid as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Non-sterile Liquid Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Non-sterile Liquid Sales by Region (2019-2024) & (K Units)
    Table 18. Global Non-sterile Liquid Sales Market Share by Region (2019-2024)
    Table 19. Global Non-sterile Liquid Sales by Region (2025-2030) & (K Units)
    Table 20. Global Non-sterile Liquid Sales Market Share by Region (2025-2030)
    Table 21. Global Non-sterile Liquid Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Non-sterile Liquid Revenue Market Share by Region (2019-2024)
    Table 23. Global Non-sterile Liquid Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Non-sterile Liquid Revenue Market Share by Region (2025-2030)
    Table 25. North America Non-sterile Liquid Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Non-sterile Liquid Sales by Country (2019-2024) & (K Units)
    Table 27. North America Non-sterile Liquid Sales by Country (2025-2030) & (K Units)
    Table 28. North America Non-sterile Liquid Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Non-sterile Liquid Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Non-sterile Liquid Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Non-sterile Liquid Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Non-sterile Liquid Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Non-sterile Liquid Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Non-sterile Liquid Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Non-sterile Liquid Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Non-sterile Liquid Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Non-sterile Liquid Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Non-sterile Liquid Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Non-sterile Liquid Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Non-sterile Liquid Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Non-sterile Liquid Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Non-sterile Liquid Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Non-sterile Liquid Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Non-sterile Liquid Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Non-sterile Liquid Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Non-sterile Liquid Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Non-sterile Liquid Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Non-sterile Liquid Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Non-sterile Liquid Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Non-sterile Liquid Sales (K Units) by Type (2019-2024)
    Table 51. Global Non-sterile Liquid Sales (K Units) by Type (2025-2030)
    Table 52. Global Non-sterile Liquid Sales Market Share by Type (2019-2024)
    Table 53. Global Non-sterile Liquid Sales Market Share by Type (2025-2030)
    Table 54. Global Non-sterile Liquid Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Non-sterile Liquid Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Non-sterile Liquid Revenue Market Share by Type (2019-2024)
    Table 57. Global Non-sterile Liquid Revenue Market Share by Type (2025-2030)
    Table 58. Global Non-sterile Liquid Price (US$/Unit) by Type (2019-2024)
    Table 59. Global Non-sterile Liquid Price (US$/Unit) by Type (2025-2030)
    Table 60. Global Non-sterile Liquid Sales (K Units) by Application (2019-2024)
    Table 61. Global Non-sterile Liquid Sales (K Units) by Application (2025-2030)
    Table 62. Global Non-sterile Liquid Sales Market Share by Application (2019-2024)
    Table 63. Global Non-sterile Liquid Sales Market Share by Application (2025-2030)
    Table 64. Global Non-sterile Liquid Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Non-sterile Liquid Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Non-sterile Liquid Revenue Market Share by Application (2019-2024)
    Table 67. Global Non-sterile Liquid Revenue Market Share by Application (2025-2030)
    Table 68. Global Non-sterile Liquid Price (US$/Unit) by Application (2019-2024)
    Table 69. Global Non-sterile Liquid Price (US$/Unit) by Application (2025-2030)
    Table 70. Nycomed Corporation Information
    Table 71. Nycomed Description and Business Overview
    Table 72. Nycomed Non-sterile Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 73. Nycomed Non-sterile Liquid Product
    Table 74. Nycomed Recent Developments/Updates
    Table 75. AbbVie Corporation Information
    Table 76. AbbVie Description and Business Overview
    Table 77. AbbVie Non-sterile Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 78. AbbVie Non-sterile Liquid Product
    Table 79. AbbVie Recent Developments/Updates
    Table 80. Aenova Corporation Information
    Table 81. Aenova Description and Business Overview
    Table 82. Aenova Non-sterile Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 83. Aenova Non-sterile Liquid Product
    Table 84. Aenova Recent Developments/Updates
    Table 85. APPCO Corporation Information
    Table 86. APPCO Description and Business Overview
    Table 87. APPCO Non-sterile Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 88. APPCO Non-sterile Liquid Product
    Table 89. APPCO Recent Developments/Updates
    Table 90. Atral Pharmaceutical Corporation Information
    Table 91. Atral Pharmaceutical Description and Business Overview
    Table 92. Atral Pharmaceutical Non-sterile Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 93. Atral Pharmaceutical Non-sterile Liquid Product
    Table 94. Atral Pharmaceutical Recent Developments/Updates
    Table 95. Aurigene Pharmaceutical Services Corporation Information
    Table 96. Aurigene Pharmaceutical Services Description and Business Overview
    Table 97. Aurigene Pharmaceutical Services Non-sterile Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 98. Aurigene Pharmaceutical Services Non-sterile Liquid Product
    Table 99. Aurigene Pharmaceutical Services Recent Developments/Updates
    Table 100. Biological E. Ltd. Corporation Information
    Table 101. Biological E. Ltd. Description and Business Overview
    Table 102. Biological E. Ltd. Non-sterile Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 103. Biological E. Ltd. Non-sterile Liquid Product
    Table 104. Biological E. Ltd. Recent Developments/Updates
    Table 105. BioPlus Life Sciences Corporation Information
    Table 106. BioPlus Life Sciences Description and Business Overview
    Table 107. BioPlus Life Sciences Non-sterile Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 108. BioPlus Life Sciences Non-sterile Liquid Product
    Table 109. BioPlus Life Sciences Recent Developments/Updates
    Table 110. Bora Pharmaceuticals Corporation Information
    Table 111. Bora Pharmaceuticals Description and Business Overview
    Table 112. Bora Pharmaceuticals Non-sterile Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 113. Bora Pharmaceuticals Non-sterile Liquid Product
    Table 114. Bora Pharmaceuticals Recent Developments/Updates
    Table 115. Cambrex Corporation Corporation Information
    Table 116. Cambrex Corporation Description and Business Overview
    Table 117. Cambrex Corporation Non-sterile Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 118. Cambrex Corporation Non-sterile Liquid Product
    Table 119. Cambrex Corporation Recent Developments/Updates
    Table 120. JGL d.d. Corporation Information
    Table 121. JGL d.d. Description and Business Overview
    Table 122. JGL d.d. Non-sterile Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 123. JGL d.d. Non-sterile Liquid Product
    Table 124. JGL d.d. Recent Developments/Updates
    Table 125. Mikart Corporation Information
    Table 126. Mikart Description and Business Overview
    Table 127. Mikart Non-sterile Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 128. Mikart Non-sterile Liquid Product
    Table 129. Mikart Recent Developments/Updates
    Table 130. PharmaVision Corporation Information
    Table 131. PharmaVision Description and Business Overview
    Table 132. PharmaVision Non-sterile Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 133. PharmaVision Non-sterile Liquid Product
    Table 134. PharmaVision Recent Developments/Updates
    Table 135. Pierre Fabre Corporation Information
    Table 136. Pierre Fabre Description and Business Overview
    Table 137. Pierre Fabre Non-sterile Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 138. Pierre Fabre Non-sterile Liquid Product
    Table 139. Pierre Fabre Recent Developments/Updates
    Table 140. TriRx Pharmaceutical Services Corporation Information
    Table 141. TriRx Pharmaceutical Services Description and Business Overview
    Table 142. TriRx Pharmaceutical Services Non-sterile Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 143. TriRx Pharmaceutical Services Non-sterile Liquid Product
    Table 144. TriRx Pharmaceutical Services Recent Developments/Updates
    Table 145. UI Pharmaceuticals Corporation Information
    Table 146. UI Pharmaceuticals Description and Business Overview
    Table 147. UI Pharmaceuticals Non-sterile Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 148. UI Pharmaceuticals Non-sterile Liquid Product
    Table 149. UI Pharmaceuticals Recent Developments/Updates
    Table 150. Wasdell Group Corporation Information
    Table 151. Wasdell Group Description and Business Overview
    Table 152. Wasdell Group Non-sterile Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 153. Wasdell Group Non-sterile Liquid Product
    Table 154. Wasdell Group Recent Developments/Updates
    Table 155. Key Raw Materials Lists
    Table 156. Raw Materials Key Suppliers Lists
    Table 157. Non-sterile Liquid Distributors List
    Table 158. Non-sterile Liquid Customers List
    Table 159. Non-sterile Liquid Market Trends
    Table 160. Non-sterile Liquid Market Drivers
    Table 161. Non-sterile Liquid Market Challenges
    Table 162. Non-sterile Liquid Market Restraints
    Table 163. Research Programs/Design for This Report
    Table 164. Key Data Information from Secondary Sources
    Table 165. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Non-sterile Liquid
    Figure 2. Global Non-sterile Liquid Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Non-sterile Liquid Market Share by Type in 2023 & 2030
    Figure 4. Solution Product Picture
    Figure 5. Suspension Product Picture
    Figure 6. Gel Product Picture
    Figure 7. Syrup Product Picture
    Figure 8. Ethanolic Liquid Product Picture
    Figure 9. Global Non-sterile Liquid Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 10. Global Non-sterile Liquid Market Share by Application in 2023 & 2030
    Figure 11. Human Medication
    Figure 12. Nutraceuticals
    Figure 13. Cosmetics
    Figure 14. Medical Devices
    Figure 15. Global Non-sterile Liquid Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Non-sterile Liquid Market Size (2019-2030) & (US$ Million)
    Figure 17. Global Non-sterile Liquid Sales (2019-2030) & (K Units)
    Figure 18. Global Non-sterile Liquid Average Price (US$/Unit) & (2019-2030)
    Figure 19. Non-sterile Liquid Report Years Considered
    Figure 20. Non-sterile Liquid Sales Share by Manufacturers in 2023
    Figure 21. Global Non-sterile Liquid Revenue Share by Manufacturers in 2023
    Figure 22. The Global 5 and 10 Largest Non-sterile Liquid Players: Market Share by Revenue in 2023
    Figure 23. Non-sterile Liquid Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 24. Global Non-sterile Liquid Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 25. North America Non-sterile Liquid Sales Market Share by Country (2019-2030)
    Figure 26. North America Non-sterile Liquid Revenue Market Share by Country (2019-2030)
    Figure 27. United States Non-sterile Liquid Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. Canada Non-sterile Liquid Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. Europe Non-sterile Liquid Sales Market Share by Country (2019-2030)
    Figure 30. Europe Non-sterile Liquid Revenue Market Share by Country (2019-2030)
    Figure 31. Germany Non-sterile Liquid Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. France Non-sterile Liquid Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. U.K. Non-sterile Liquid Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Italy Non-sterile Liquid Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. Russia Non-sterile Liquid Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. Asia Pacific Non-sterile Liquid Sales Market Share by Region (2019-2030)
    Figure 37. Asia Pacific Non-sterile Liquid Revenue Market Share by Region (2019-2030)
    Figure 38. China Non-sterile Liquid Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Japan Non-sterile Liquid Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. South Korea Non-sterile Liquid Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. India Non-sterile Liquid Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Australia Non-sterile Liquid Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. China Taiwan Non-sterile Liquid Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Non-sterile Liquid Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Latin America Non-sterile Liquid Sales Market Share by Country (2019-2030)
    Figure 46. Latin America Non-sterile Liquid Revenue Market Share by Country (2019-2030)
    Figure 47. Mexico Non-sterile Liquid Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Brazil Non-sterile Liquid Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Argentina Non-sterile Liquid Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Middle East & Africa Non-sterile Liquid Sales Market Share by Country (2019-2030)
    Figure 51. Middle East & Africa Non-sterile Liquid Revenue Market Share by Country (2019-2030)
    Figure 52. Turkey Non-sterile Liquid Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. Saudi Arabia Non-sterile Liquid Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. UAE Non-sterile Liquid Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 55. Global Sales Market Share of Non-sterile Liquid by Type (2019-2030)
    Figure 56. Global Revenue Market Share of Non-sterile Liquid by Type (2019-2030)
    Figure 57. Global Non-sterile Liquid Price (US$/Unit) by Type (2019-2030)
    Figure 58. Global Sales Market Share of Non-sterile Liquid by Application (2019-2030)
    Figure 59. Global Revenue Market Share of Non-sterile Liquid by Application (2019-2030)
    Figure 60. Global Non-sterile Liquid Price (US$/Unit) by Application (2019-2030)
    Figure 61. Non-sterile Liquid Value Chain
    Figure 62. Non-sterile Liquid Production Process
    Figure 63. Channels of Distribution (Direct Vs Distribution)
    Figure 64. Distributors Profiles
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Medical Microbial Incubators - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-30W13258
Thu Nov 07 00:00:00 UTC 2024

Add to Cart

Cannabinoid Derived Pharmaceutical - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-37I13965
Wed Nov 06 00:00:00 UTC 2024

Add to Cart

Drugs for the Treatment of Hemarthrosis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-13Q14166
Wed Nov 06 00:00:00 UTC 2024

Add to Cart

Drugs to Treat Hyperkalemia - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-28I12677
Wed Nov 06 00:00:00 UTC 2024

Add to Cart